Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Healthcare providers ...
Morning Overview on MSN
Long-read RNA sequencing tool boosts rare-disease diagnoses missed by DNA tests
For years, two siblings with the distinctive facial features of Treacher Collins syndrome had no genetic explanation for ...
Demand for germline hereditary cancer genetic testing has increased because of reduced cost, gene discovery, expanding indications, and precision cancer therapies. The traditional model for germline ...
Everyday Health on MSN
Genetic testing and ATTR-CM: Everything you need to know
Learn why genetic testing is vital for ATTR-CM diagnosis, how it identifies hereditary risks for family members, and the ...
Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease Women age 20-79 years diagnosed ...
PlexusDx launches the first dedicated at-home genetic test for peptide biology, covering 14 pathways, 49 peptides, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results